GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Elekta AB (OTCPK:EKTAY) » Definitions » Valuation Rank

Elekta AB (Elekta AB) Valuation Rank


View and export this data going back to 2008. Start your Free Trial

What is Elekta AB Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Elekta AB Valuation Rank Related Terms

Thank you for viewing the detailed overview of Elekta AB's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Elekta AB (Elekta AB) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Elekta AB (OTCPK:EKTAY) » Definitions » Valuation Rank
Comparable Companies
OSTO:BONEX OSTO:BIOT OSTO:ALIF B OSTO:SYNSAM OSTO:TDVOX OSTO:ADDV A OSTO:DOXA XSAT:BPCINS OSTO:QLINEA OSTO:ORTI A ISRG XPAR:EL BDX TSE:7741 XSWX:ALC OCSE:COLO B RMD WST XPAR:DIM TSE:4543
Traded in Other Exchanges
EKTAF:USA EKTA B:Sweden EKTAB:Mexico EKTABs:UK 0O5H:UK EJXB:Germany
Address
Kungstensgatan 18, Box 7593, Stockholm, SWE, SE-103 93
Website
https://www.elekta.com
Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company's installed base of more than 5,000 linear accelerators, GammaKnife and Unity platforms, and software is used in more than 6,000 hospitals globally. The company's sales are evenly distributed across geographies, with North and South America accounting for 31%; Europe, the Middle East, and Africa accounting for 35%; and Asia-Pacific contributing the remainder.